ZetrOZ has announced that the US Food and Drug Administration (FDA) has granted 510(k) clearance for the marketing of its ultrasound pain management device sam, a wearable, long-duration, ultrasonic diathermy device for use in applying deep ...
Tags: Ultrasound Therapy Device, Medicine, FDA
Iroko Pharmaceuticals, LLC, a global specialty pharmaceutical company dedicated to advancing the science of analgesia, announced that the U.S. Food and Drug Administration (FDA) has accepted for review the Supplemental New Drug Application ...
Tags: Iroko Pharmaceuticals, FDA, ZORVOLEX, osteoarthritis pain
Iroko Pharmaceuticals, LLC, a global specialty pharmaceutical company dedicated to advancing the science of analgesia, announced that the U.S. Food and Drug Administration (FDA) has accepted for review the Supplemental New Drug Application ...
OligoMedic, a manufacturer of osteoarthritis products, has announced that it will launch its JointRep product, an injectable implant designed to treat cartilage articular joint defects and reduce articular pain. JointRep is a simple ...
DJO Global has introduced OA Nano knee brace to reduce pain and enhance stability in patients with mild-to-moderate osteoarthritis. The new knee brace is manufactured using a new kind of metal that is as light as magnesium with the ...
Tags: DJO Global, OA Nano knee brace, reduce pain, enhance stability
Eli Lilly and Company has met the United States Food and Drug Administration (FDA) requirements for pediatric exclusivity for Cymbalta (duloxetine HCl), which is available in 20-mg, 30-mg, and 60-mg capsules. As part of the approval, ...